Sale!

Paul Langlois – PESI – Pharmacology of Infectious Diseases and Immunizations

$22

INSTANT DELIVERY !!!

Please check your email ( spam, junk box) after your order

Link will be sent to you in a hour

Description

Description

Paul Langlois – PESI – Pharmacology of Infectious Diseases and Immunizations download, Paul Langlois – PESI – Pharmacology of Infectious Diseases and Immunizations review, Paul Langlois – PESI – Pharmacology of Infectious Diseases and Immunizations free

Paul Langlois – PESI – Pharmacology of Infectious Diseases and Immunizations

Speaker: Paul Langlois, APN, PhD, CCRN, CCNS

Duration: 5 Hours 45 Minutes

Format: Audio and Video

Copyright: Oct 17, 2017

Media Type: Digital Seminar

Description

  • Antimicrobials
  • Preventive strategies to limit antimicrobial resistance
  • C. Difficile
  • UTIs
  • Respiratory Infections
  • Skin Infections
  • Treatment (IDSA) guidelines
  • Immunizations (Adult)

Attend this seminar and learn proper prescribing, patient education and monitoring procedures for a variety of drug regimens used to treat common acute and chronic infectious diseases. Choosing an antibacterial agent can be challenging, given the plethora of drugs available on the market and the emerging trend in bacterial resistance.

You will learn the pharmacology of different classes of antimicrobials used to treat infectious disease states encountered in clinical practice. Discover the spectrums of activity, pharmacokinetic characteristics and parameters for monitoring therapeutic outcomes. Emphasis is placed on the new antimicrobials and advances in evidence-based treatment guidelines. You will leave this seminar better prepared to design appropriate and cost-effective drug regimens for improved therapeutic outcomes.

Speaker

Paul Langlois, APN, PhD, CCRN, CCNS

Paul Langlois, APN, PhD, CCRN, CCNS, is a critical care clinical specialist in the surgical, medical, neurologic, burn, CCU, and trauma ICUs of Cook County Hospital, Chicago. Drawing on over 40 years of experience assessing and managing patients with life-threatening diseases, Dr. Langlois provides advanced-level training to nurses, physician assistants, nurse practitioners, respiratory therapists, and physicians.

Dr. Langlois is committed to providing the highest quality of care to patients through advanced education. His presentations are evidence-based, timely, and provide participants with numerous case studies to facilitate critical thinking. As a bedside clinical nurse specialist, he has developed several institution-wide protocols for the multidisciplinary assessment and management of infectious disease and multi-system organ failure patients.

His presentations are enthusiastically delivered and offer highly practical tips that help make the most challenging concepts easy to understand. Linking knowledge to clinical practice is the goal of every educational program.

Speaker Disclosures:
Financial: Dr. Paul Langlois has employment relationships with Cook County Hospital and Emergency Care Consultants. He receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Paul Langlois is a member of the American Nurses Association, the American Association of Critical Care Nurses, and the Society of Critical Care Medicine.

Target Audience

Nurses, Pharmacists and Physician Assistants

Outline

Bacterial Characteristics

  • Cell envelope characteristics
  • Gram stain procedures
  • Gram positive & Gram negative organisms

Antibiotic Prescribing Background

  • Interpreting culture & sensitivity
  • Inhibitory concentration vs. bactericidal concentration
  • Empiric vs. targeted therapy
  • Antibiogram

Medication Allergy vs. Adverse Effect

  • Defining true allergic response
  • PCN-Carbapenem cross reactivity

Antibiotic Resistance

  • MRSA
  • VRE
  • Extended Spectrum Beta-Lactamases
  • Klebsiella Pneumoniae
  • Carbapenemase

Drug Resistant Threats in the U.S.

  • C. Diff
  • CRE
  • Neisseria Gonorrhea
  • Tuberculosis

Current CDC Guidelines

  • Antibiotic stewardship
  • Start and stop recommendations

NEW Antibiotics for 2017

  • Signs & symptoms
  • Causative organisms
  • Pharmacologic management
  • Non-pharmacologic management for:
  • Pneumonia
  • Bronchitis
  • Sinusitis
  • Pharyngitis
  • Acute Cystitis
  • Catheter-related UTIs
  • Pelvic Inflammatory Disease
  • Brain Abscess
  • Meningitis
  • Cellulitis
  • Diabetic Foot Ulcers
  • Osteomyelitis
  • Influenza
  • Human & Animal bites

Common Effects of Antibiotics on Other Medications

  • Cardiac medications
  • Anti-seizure medications
  • Anticoagulants
  • Antifungal agents

Bioterrorism: Diagnosis & Treatment

  • Bacillus anthracis
  • Clostridium botulinum
  • Yersinia pestis
  • Francisella tularensis

CDC Immunization Schedule for Adults

  • Types of vaccines
  • Indications & Contraindications

Objectives

  • Analyze the major classes of antibiotics and their pharmacokinetic characteristics.
  • Apply current evidenced-based approaches to select appropriate treatment regimens for common infections encountered in clinical practice.
  • Distinguish between different types of bacterial etiology and mechanisms of resistance.
  • Compare empiric dosing of antimicrobials.
  • Recognize important interactions between antimicrobials and other drugs.
  • Plan goals of therapy and parameters for monitoring therapeutic response to antimicrobials.
  • Recommend specific antimicrobial therapeutic drug monitoring to maximize efficacy and minimize toxicities (e.g., vancomycin and aminoglycosides).
  • Develop preventative strategies to limit antimicrobial resistance.
  • Design patient and caregiver education on the proper use of antimicrobials.
  • Differentiate local and global ecological factors affecting promotion of viral infection emergence.
  • Plan for vaccines that are currently recommended for routine administration.

Frequently Asked Questions:

  1. Innovative Business Model:
    • Embrace the reality of a genuine business! Our approach involves forming a group buy, where we collectively share the costs among members. Using these funds, we purchase sought-after courses from sale pages and make them accessible to individuals facing financial constraints. Despite potential reservations from the authors, our customers appreciate the affordability and accessibility we provide.
  2. The Legal Landscape: Yes and No:
    • The legality of our operations falls into a gray area. While we lack explicit approval from the course authors for resale, there’s a technicality at play. When procuring the course, the author didn’t specify any restrictions on resale. This legal nuance presents both an opportunity for us and a boon for those seeking budget-friendly access.
  3. Quality Assurance: Unveiling the Real Deal:
    • Delving into the heart of the matter – quality. Acquiring the course directly from the sale page ensures that all documents and materials are identical to those obtained through conventional means. However, our differentiator lies in going beyond personal study; we take an extra step by reselling. It’s important to note that we are not the official course providers, meaning certain premium services aren’t included in our package:
      • No coaching calls or scheduled sessions with the author.
      • No access to the author’s private Facebook group or web portal.
      • No entry to the author’s exclusive membership forum.
      • No direct email support from the author or their team.

    We operate independently, aiming to bridge the affordability gap without the additional services offered by official course channels. Your understanding of our unique approach is greatly appreciated.

Refund is acceptable:

  • Firstly, item is not as explained
  • Secondly, Item do not work the way it should.
  • Thirdly, and most importantly, support extension can not be used.

Thank you for choosing us! We’re so happy that you feel comfortable enough with us to forward your business here.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Paul Langlois – PESI – Pharmacology of Infectious Diseases and Immunizations”

Your email address will not be published.